FERROGRAD

This brand name is authorized in Ireland, Malta, New Zealand, UK.

Active ingredients

The drug FERROGRAD contains one active pharmaceutical ingredient (API):

1	Ferrous sulfate UNII 39R4TAN1VT - FERROUS SULFATE
	Iron sulphate is a co-factor of various enzymes necessary for the transfer of energy (eg. cytochrome oxidase, xanthine oxidase). Iron is also present in hemoglobin and myoglobin, which are essential for the transport and use of oxygen.
	Read more about Ferrous sulfate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FERROGRAD Prolonged release tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AA07	Ferrous sulfate	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AA Iron bivalent, oral preparations
Discover more medicines within B03AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	21929
IE	Health Products Regulatory Authority	76597
MT	Medicines Authority	AA1438/07101, AA521/00105, AA770/14702
NZ	Medicines and Medical Devices Safety Authority	706